L

Ligand Pharmaceuticals

LGND

104.410
USD
-4.76
(-4.36%)
Market Closed
Volume
2,360
EPS
0
Div Yield
0
P/E
46
Market Cap
1,943,998,970
Related Instruments
A
ALNY
31.19
(13.13%)
268.66 USD
AMGN
2.78
(0.84%)
335.22 USD
A
ASMB
-0.440
(-2.95%)
14.470 USD
K
KOD
-0.03000
(-1.03%)
2.88000 USD
R
RPTX
-0.33000
(-8.82%)
3.41000 USD
S
SITC
0.015
(0.10%)
15.460 USD
S
SLDB
-0.24000
(-2.68%)
8.70000 USD
Z
ZYME
-0.340
(-3.25%)
10.120 USD
News

Title: Ligand Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.